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Results: 21 pts (9%) presented with type 1 in at least 1 peripheral leads:
16 pts (7%) in aVR lead, 5 pts in inferior leads and none in lateral leads. Type
1 in limb leads was associated with a type 1 in right precordial leads in each
pt, and was spontaneous in 8 pts (38%) and induced by drug challenge in
13 pts (62%). 15 of them have results of genetic testing (7 had SCN5A mutation).
There was a trend toward longer PR interval in patients with type 1 ECG
in limb leads (192±39 ms vs 176±35ms, p=0.09).
These patients present more frequently with arrhythmic events (57% vs
33%, p=0.009), with syncope (48% vs. 26%, p=0.0002), ICD appropriated
therapies (24% vs. 6%, p<0.001) and a trend toward more frequent SD (10%
vs 4%, p=0.1).
In multivariate analysis, type 1 ECG in limb leads was independently asso-
ciated with arrhythmic events (OR 3.08, [1.17-8.1], p=0.022) or with SD or
appropriate ICD therapy (OR 4.5 [1.32-15.3], p=0.016).
Conclusion: Type 1 Brugada pattern in peripheral limb ECG leads can be
seen in around 10% in patients with BS, mostly in aVR lead but also in infe-
rior leads. Type 1 ST elevation in limb leads is an independent predictive
factor of arrhythmic event in BS patients. This simple ECG parameter could
be used for further risk stratification.
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Introduction: Risk stratification in Brugada syndrome (BS) remains a key
issue. Cardiac autonomic dysfunction has been proposed as a precipitating
factor of arrhythmic events in BS. The aim of the present study was to assess
cardiac response to autonomic innervation using heart rate variability (HRV),
in symptomatic patients with a BS compared to asymptomatic patients.
Methods: Twenty-two patients with BS were studied. Group S (mean
age=45.5±11 years, men: n=9) consisted of 10 symptomatic patients (3 cardiac
arrest, 4 syncope, 1 nocturnal convulsions and 2 lipothymia) and group A
(mean age=39.9±13.9 years, men: n=5) of 12 asymptomatic patients. HRV
was obtained, using dedicated software, on 24 hours Holter recording. We
studied time and frequency domains during a day-period (16h-20h) and a
night-period (0h-4h), using mean values and variation coefficients for each
period.
Results: In time and frequency domain, no difference was found between
the 2 groups, during the whole recording, night or day period. During night
period, patients from group S have higher variations than patients from group
A for HFn.u. (45.9±10.5 vs 34.6±13%, p<0.05) and LF/HF (56.7±10.7 vs
44.2±18, p<0.05). No difference was found during day. This higher variation
of frequency domain parameters during night in symptomatic patients relates
a more variable sinusal node response to the cardiac autonomic innervation.
Conclusion: Symptomatic patients with BS have higher variations of car-
diac response to the autonomic innervation during night resulting from either
higher sinus node sensitivity to autonomic influx or higher variation of these
influxes. The occurrence of symptoms in BS will be underlined by sponta-
neous higher variations of cardiac response to autonomic nervous system
especially during night.
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Introduction: Antitachycardia pacing (ATP) is a painless therapy reducing
shocks in implantable cardioverter-defibrillator (ICD) recipients. One or 2 ATP
attempts are usually programmed to terminate fast ventricular tachycardia (FVT)
episodes without delaying successful shock if ATP fails. Programming more ATP
attempts could probably reduce the occurrence of shocks.
Objective: We sought to analyze the long-term efficacy and safety of pro-
gramming a high number of ATP attempts for FVT.
Methods: Patients receiving a first ICD for coronary artery disease and
dilated cardiomyopathy in primary and secondary prevention indications
between 2000 and 2009 were prospectively included. ICDs were programmed
to deliver 10 ATP attempts for FVT cycle lengths (CL) of 250 to 300 ms (200
to 240 bpm) before shock delivery (5 bursts then 5 ramps; 10 pulses at 81 to
88% of the FVT CL; minimal pacing CL 180 ms).
Results: 770 patients were prospectively included and followed for
40±25 months. Among them, 137 patients (17.8%) had a total of 1839 epi-
sodes of FVT (rate 209±9 bpm). ATP terminated 1713 episodes of FVT (effi-
cacy, 93.1%) and accelerated 5.8% of episodes. A majority of episodes were
successfully treated (98.3%) by 1 or 2 ATP attempts. Conversely, the patient-
based analysis showed that 17 (12.4%), 8 (5.8%) and 5 patients (2.1%) had
one episode or more treated by at least 3, 4 or 5 ATP attempts, respectively.
These patients would have been shocked with a conventional ICD program-
ming. The benefit of this strategy was reduced for 6 to 10 attempts and only
10 patients were shocks for ATP failure (20 episodes, 1.1%). Despite the high
number of attempts programmed, FVT episodes were mainly asymptomatic
and found during device interrogation: syncope and pre-syncope occurred in
0.2% and 0.4% of episodes, respectively.
Conclusion: Programming a high number of ATP attempts (at least 4 or 5
ATP attempts) for FVT is both safe and useful. It could prevent painful shocks
in a high proportion of ICD recipients.
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Introduction: the assessment of the arrhythmia risk is an important issue
after myocardial infarction (MI). The role of autonomic nervous system in
arrhythmia stratification risk is well validated. Holter parameters can reflect
both components of the autonomic nervous system: the sympathic and the
parasympathic. There is little data concerning the relation between risk strati-
fication parameters and the MI localization.
Aim: Comparison of Holter parameters exploring the autonomic nervous
system in patients having anterior and inferior myocardial infarction.
Methods: This prospective study included 90 patients (mean age 58±10 years)
hospitalized for recent myocardial infarction who underwent 24 hour Holter
monitoring. We analysed the number of premature beats(PB), heart rate vari-
ability (HRV) parameters (SDNN, RMSSD), QT intervals and heart rate tur-
bulence (TO et TS)
Results: 50 patients had anterior MI and 40 patients had inferior MI. There
was no significant difference between both groups regarding HRV and heart
rate turbulence. Where as in patients having anterior MI the QT interval was
significantly longer than in patients having inferior MI.
Table – Results
Anterior MI 
(n=50)
Inferior MI 
(n=40)
p
Number PB/ 24H 46±8 52±8 NS
SDNN 92±39 104±34 NS
RMSSD 40±20 36±21 NS
QT apex 349±27 340±22 NS
QT end 431±33 416±24 0.03
TO – 0.011 – 0.007 NS
TS 8.41 9.37 NS
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Conclusion: HRV and heart rate turbulence parameters are not affected by MI
localization. Anterior MI localization is associated with ventricular repolarization
heterogeneity suggesting higher risk of arrhythmia in this population.
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Introduction: Isthmus-dependent (ID) clockwise (CW) atrial flutters (AFl)
are rare in comparison with counterclockwise (CCW) AFl. Little is known
about clinical and electrophysiological characteristics of CW AFl occurring
after previous radiofrequency (RF) catheter ablation of CCW AFl. We ought
to compare CW AFl “de novo” versus CW AFl occurring after previous CCW
AFl RF ablation.
Methods and results: From January 2007 to January 2010, out of 246 pro-
cedures of RF catheter ablation for AFl were reviewed. Patients were excluded
if they were in sinus rhythm (n=70) at the beginning of the procedure, or if
AFl was not ID (n=118). 25 patients presented CW AFl (10% of all ID AFl),
including 10 CW AFl occurring after a previous RF catheter ablation for CCW
AFl. Mean time for recurrence after the previous procedure of CCW AFl RF
ablation was 3,5y. They were younger (61,6 y±11) than patients with CW AFl
de novo (74,0 y±7,2; p=0,005). Bidirectionnal isthmus block was obtained in
all patients. There was a significant difference in terms of double potentials
intervals after ablation (155±31 ms for CW AFl de novo versus 111±7 ms for
recurrent CW AFl; p=0,028). No differences were observed concerning
CHADS score, AFl cycle length, and ECG typical pattern for CW AFl
between the two groups.
Conclusion: Patients with CW AFl occurrence after CCW AFl RF catheter
ablation are younger than patients presenting with CW AFl “de novo”. They
have a smaller interspike interval after block completion, suggesting a smaller
or a more rapidly conducting atrium.
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Introduction: In patients with atrial fibrillation (AF), cryoballoon can be
used to achieve pulmonary vein isolation (PVI) but is associated with about 1/3 of
AF recurrences. The objective of this prospective study is to evaluate the ben-
efit of redo procedures with RF, after failure of the initial catheter ablation of
AF using cryotherapy.
Methods: Circumferential PVI was first performed using a cryoballoon
catheter in 60 consecutive patients with symptomatic paroxysmal AF
(38 males, age 57±9 years). In case of tachyarrhythmia recurrence, a second
procedure was performed using RF energy.
Results: At 4±2 months follow up after cryoballoon PVI, 24 patients
(40%) had AF recurrences (15 males, age 58±10 years) and underwent a
second catheter ablation using radiofrequency. Redo procedures were
achieved under local anesthesia in 22/24 patients (92%). A 3-D mapping
system of the left atrium (LA) was used only in 2 patients (8%). Mean proce-
dure and radioscopy times were significantly shorter than those observed
during previous ablation by cryoballoon, (respectively 152±26 and 117±35 min,
P<0.001; and 29±9 and 18±11 min, P=0.001). Atrio-venous reconnections,
usually discrete, were observed in 2.8±1.3 veins per patient, most frequently in the
left inferior PV (21/24 patients, 88%; right inferior PV in 17/24 patients, 71%;
right superior PV in 14/24 patients, 58%; left superior PV in 14/24 patients, 58%;
and all PVs in 9/24 patients, 38%). Conduction gaps were readily ablated
using focal RF energy applications in all patients. After a mean of 1.5±0.8
ablations, 98% of patients were free from AF at 10±5 months follow up. No
serious complication was observed.
Conclusion: In patients with paroxysmal AF, redo procedures using RF
energy after failure of cryoballoon ablation of AF can be safely and rapidly
achieved and clearly improve outcomes of patients.
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Introduction: Radiofrequency (RF) aims to create irreversible tissue
lesions to cure atrial fibrillation (AF). Currently available parameters of RF
delivery are power, tip temperature, impedance and duration. The catheter-
tissue contact predicts experimentally RF efficacy and may (via pressure con-
trol) avoid complications. The Tacticath catheter (Endosense) measures
directly the contact force (CF) expressed in equivalent of weight (grams; g).
Purpose: We report our initial experience of AF ablation using the Tacticath.
Methods: In our center 14 patients (pts; 11 males, 57±12 years) were
ablated (june 2010-april 2011) for symptomatic, drug resistant AF, using the
Tacticath catheter connected to the Tactisys workstation. On a separate screen
(figure), Tactisys displays instantaneous CF, lateral and axial components, CF
evolution on a 15 s time scale and real-time force-time integral (FTI) during
RF delivery. Patients were monitored for acute success, complications and AF
relapse.
Results: AF was paroxysmal in 12 pts and persistent in 2. All pts but 2 had
normal hearts. Left atrium diameter was 42±6 mm. Pulmonary vein isolation
was performed in all pts and venous disconnection rate as assessed with a cir-
cular catheter was 100%. Persistent AF pts had additional RF targeting frag-
mented potentials in the left atrium. Two pts with previously documented
typical flutter also had right isthmus ablation. Average contact force during
RF was 17.7±2.8 g. Total FTI was 18306±9298 gs. RF delivery time was
17±7 min. Procedure duration (skin to skin) was 170±59 min, fluoroscopy
time 11±6 min (fluoroscopy dose 298±232 mGy). There was no complication.
Follow-up is ongoing. As to now (6 months median follow-up), only one
patient relapsed AF.
Conclusions: AF ablation with Tacticath seems efficient and safe. CF
assessment during AF ablation provides additional information which may
help avoid poor lesion creation; in addition, limiting peak forces possibly
reduces the risk of perforation.
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